Zimmerhackl LB - Search Results

1

E. coli, antibiotics, and the hemolytic-uremic syndrome.

Zimmerhackl LB. Zimmerhackl LB. N Engl J Med. 2000 Jun 29;342(26):1990-1. doi: 10.1056/NEJM200006293422611. N Engl J Med. 2000. PMID: 10874069 No abstract available.

2

New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.

Karch H, Friedrich AW, Gerber A, Zimmerhackl LB, Schmidt MA, Bielaszewska M. Karch H, et al. Among authors: zimmerhackl lb. Semin Thromb Hemost. 2006 Mar;32(2):105-12. doi: 10.1055/s-2006-939766. Semin Thromb Hemost. 2006. PMID: 16575685 Review.

3

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB; European Paediatric Study Group for HUS. Ariceta G, et al. Among authors: zimmerhackl lb. Pediatr Nephrol. 2009 Apr;24(4):687-96. doi: 10.1007/s00467-008-0964-1. Epub 2008 Sep 18. Pediatr Nephrol. 2009. PMID: 18800230

4

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.

Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Würzner R. Orth D, et al. Among authors: zimmerhackl lb. J Immunol. 2009 May 15;182(10):6394-400. doi: 10.4049/jimmunol.0900151. J Immunol. 2009. PMID: 19414792

5

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A. Bielaszewska M, et al. Among authors: zimmerhackl lb. PLoS One. 2007 Oct 10;2(10):e1024. doi: 10.1371/journal.pone.0001024. PLoS One. 2007. PMID: 17925872 Free PMC article.

6

Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.

Gerber A, Kirchhoff-Moradpour AH, Obieglo S, Brandis M, Kirschfink M, Zipfel PF, Goodship JA, Zimmerhackl LB. Gerber A, et al. Among authors: zimmerhackl lb. Pediatr Nephrol. 2003 Sep;18(9):952-5. doi: 10.1007/s00467-003-1192-3. Epub 2003 Jun 26. Pediatr Nephrol. 2003. PMID: 12836093

7

Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk.

Allerberger F, Friedrich AW, Grif K, Dierich MP, Dornbusch HJ, Mache CJ, Nachbaur E, Freilinger M, Rieck P, Wagner M, Caprioli A, Karch H, Zimmerhackl LB. Allerberger F, et al. Among authors: zimmerhackl lb. Int J Infect Dis. 2003 Mar;7(1):42-5. doi: 10.1016/s1201-9712(03)90041-5. Int J Infect Dis. 2003. PMID: 12718809

8

Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis.

Berner R, Krause MF, Gordjani N, Zipfel PF, Boehm N, Krueger M, Brandis M, Zimmerhackl LB. Berner R, et al. Among authors: zimmerhackl lb. Pediatr Nephrol. 2002 Mar;17(3):190-2. doi: 10.1007/s00467-001-0798-6. Pediatr Nephrol. 2002. PMID: 11956859

9

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.

Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Gerber A, et al. Among authors: zimmerhackl lb. J Infect Dis. 2002 Aug 15;186(4):493-500. doi: 10.1086/341940. Epub 2002 Aug 2. J Infect Dis. 2002. PMID: 12195376

10

Eculizumab for atypical hemolytic-uremic syndrome.

Nürnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M. Nürnberger J, et al. Among authors: zimmerhackl lb. N Engl J Med. 2009 Jan 29;360(5):542-4. doi: 10.1056/NEJMc0808527. N Engl J Med. 2009. PMID: 19179328 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results